ICPA,UP, Get on the train! Chart below!

New Post Public Reply Private Reply Replies (0) Message Board
perchy

ICPA,UP, Get on the train! Chart below!
http://stockcharts.com/h-sc/ui?s=icpa

 MACD Golden cross confirmed....
-------------------------------------------------------------

ICPA - This post By another but I am also the same with him!
Got in last Aug. cause of proven DD,It told me this was a serious company and that this one of a few stocks that are in the 2% of penny stocks that is Good!
-----------------------------------------------------------
Just wanted to remind everyone just how fortunate they are to have come upon this gem. Every diamond takes time to process. They are not just pulled out of the ground. If youve ever seen a diamond before they actually look like the finished, sparkly product you would see how ugly and dark and completely unshiny they are,
before all the hard work and time they take to make look like a diamond. Well that is what we have here, a diamond in the making. I feel confident about that and well I've already put a ton of money where my mouth is.
Some might say Im out of my mind to have invested as much as i have here on a sub sub penny stock. If they have done the DD that I have id say theyre crazy not to.

This IS NOT your typical crappy penny stock, no sir. I take my investments very very seriously and let's look at the facts.

One fact is that Steve takes it very serious as well. Another fact is that Steve has proved that this IS NOT a flash-in-the-pan company, he /ICPA are in this for the long haul.

Fact, Steve had every opportunity in the world to pump the crap out of this, dilute/sell shares like no tomorrow but he did not. All he has done is everything you could ask for from a real company leader.
He was kind enough to let us all in on what is in the works for the future of ICPA and that he is pretty dang sure it will all happen in the near future.

Steve is a smart, eager, motivated and already successful businessman and has probably used more of his own money to get things done than ICPA money. Now why would he do that? Steve knows a lot more then I do about the direction of this company so if he's willing to invest his own money, I sure as hell am willing to do the same and follow his lead.

This is everyone's opportunity to keep accumulating before it runs big big big. People I cannot emphasize enough how very special this is going to be.
When we start moving up it will be on true merit, real, verifiable, big revenue generating deals. It won't be because of some BS momo driven by some 3rd party pump that'll crash it in 3 days.

Does anyone truly realize what real deals will do to the pps of a subpenny stock?? It will undeniably shoot the pps well beyond 10 cents in just a short time.
We have all witnessed that the float truly is getting smaller and when deals hit the wires it wont take much volume to get passed 5 cents if people have the nads like me to hold out. I am what you would call a true long.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading

Top 5 Most Recently Viewed Articles

Novo Nordisk Stock Soars After FDA Approval of Wegovy Pill

Updated Category News Views 159

Overview of Novo Nordisk's Recent Stock Surge Novo Nordisk A/S (NYSE: NVO) has recently experienced a significant increase in its stock price, rising over 7% in premarket trading following its groundbreaking regulatory approval from the U.S. Food and Drug Administration (FDA). This approval marks an exciting development for the company, as the FDA has approved their oral...

Continue Reading
Experience Instant Withdrawals at BitStarz Casino in 2025

Updated Category News Views 215

Discover BitStarz: A Leader in Instant Payout Casinos In the world of online casinos, speed and efficiency are paramount for players eager to enjoy their winnings. BitStarz Casino stands out as a trusted platform dedicated to delivering instant withdrawals and fast payouts, making it a must-visit for online gaming enthusiasts in 2025. Why BitStarz is the Go-To Casino for...

Continue Reading
Gridora: A New Era for Strategic Infrastructure Development

Updated Category News Views 588

Introducing Gridora: A Groundbreaking Infrastructure Venture The establishment of Gridora marks an exciting shift in how strategic infrastructure projects will be developed. Created as a joint venture involving major entities ADQ, IHC, and Modon Holding, this new platform is set to enhance the collaborative efforts between the public and private sectors. With a shared...

Continue Reading
WisdomTree Highlights Monthly Performance Metrics Update

Updated Category News Views 50

WisdomTree Monthly Performance Review WisdomTree, Inc. (NYSE: WT), a notable player in financial innovation, has recently released an in-depth report detailing its monthly performance metrics. This report highlights impressive growth and offers valuable insights into the company’s assets under management (AUM) and fund flow performance. As a vital participant in the...

Continue Reading
Trump's Comments Spark Controversy Over Jury Pool Integrity

Updated Category News Views 217

Recent Legal Developments in Phoenix In a notable case linked to a police shooting, Attorney Dave Erlichman of Comeback Law P.C. represents Essa Williams, who faces criminal charges after shooting Phoenix Police Officer Tyler Moldovan. Williams's defense hinges on self-defense claims, but recent statements by former President Trump have introduced significant controversy...

Continue Reading